Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Unknown × zimberelimab × Clear all

Phase

Phase 2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Biliary Carcinoma 1

Interventions

Exercise 47 Blood Specimen Collection 47 Radiotherapy 40 Standard of Care 30 Radiosurgery 30 Drug Therapy 28 Surgical Procedures, Operative 25 Magnetic Resonance Spectroscopy 25 Acupuncture Therapy 24 Biopsy 22 Cyclophosphamide 21 Cisplatin 19 Magnetic Resonance Imaging 18 Laparoscopy 17 Control Groups 17 Endoscopic Mucosal Resection 16 Saline Solution 15 camrelizumab 14 Radiofrequency Ablation 14 Propofol 14 Surveys and Questionnaires 13 Preoperative Exercise 13 Cytarabine 13 apatinib 12 anlotinib 12 Radiotherapy, Intensity-Modulated 12 Metformin 12 Injections 12 Neoadjuvant Therapy 11 Hepatectomy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05540483 2022-09-16

RIGHT

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown

Gastrointestinal

Biliary Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡